Video Latest - ecancer

PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Dr Mary O'Brien - The Royal Marsden NHS Foundation Trust, London, UK

14 Sep 2016

Editor's Choice for August 2016

Prof Gordon McVie - Editor in Chief, ecancer

22 Aug 2016

Breaking down barriers to cancer communication worldwide

Prof Gordon McVie - Editor in Chief, ecancer

19 Aug 2016

Drug repurposing in review

Dr Farhat Khanim – University of Birmingham, Birmingham, UK

5 Aug 2016

Tumour metabolism in chemoprevention

Dr Farhat Din – The University of Edinburgh, Edinburgh, UK

4 Aug 2016

Bring patient voices into research

Maggie Wilcox - Independent Cancer Patients' Voice, UK

4 Aug 2016

Patient advocacy in breast cancer research

Maired Mackenzie - Independent Cancer Patients' Voice, UK

4 Aug 2016

Chemoprevention of breast cancer recurrence

Prof Rob Coleman – The University of Sheffield, Sheffield, UK

4 Aug 2016

Societal barriers to chemoprevention

Dr Andrea De Censi - E.O. Ospedali Galliera, Genova, Italy

4 Aug 2016

Chemoprevention of platelet crosstalk in cancer

Prof Carlo Patrono - Catholic University School of Medicine, Rome, Italy

4 Aug 2016

The future of cancer prevention

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom

4 Aug 2016

Update on CaPP3 in high risk populations

Prof Sir John Burn – Institute of Genetic Medicine, Newcastle, UK

4 Aug 2016

Video